Cargando…
Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children
BACKGROUND AND PURPOSE: The myelin oligodendrocyte glycoprotein (MOG) antibody is detected at a high rate in childhood acquired demyelinating syndrome (ADS). This study aimed to determine the diagnostic value of the MOG antibody in ADS and the spectrum of MOG-antibody-positive demyelinating diseases...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354962/ https://www.ncbi.nlm.nih.gov/pubmed/32657068 http://dx.doi.org/10.3988/jcn.2020.16.3.461 |
_version_ | 1783558193114251264 |
---|---|
author | Yoo, Il Han Kim, WooJoong Shim, Youngkyu Choi, Sun Ah Kim, Soo Yeon Kim, Hunmin Lim, Byung Chan Hwang, Hee Choi, Jieun Kim, Ki Joong Kim, Yeseul Hyun, Jae-Won Kim, Su-Hyun Choi, Kyungho Kim, Ho Jin Chae, Jong-Hee |
author_facet | Yoo, Il Han Kim, WooJoong Shim, Youngkyu Choi, Sun Ah Kim, Soo Yeon Kim, Hunmin Lim, Byung Chan Hwang, Hee Choi, Jieun Kim, Ki Joong Kim, Yeseul Hyun, Jae-Won Kim, Su-Hyun Choi, Kyungho Kim, Ho Jin Chae, Jong-Hee |
author_sort | Yoo, Il Han |
collection | PubMed |
description | BACKGROUND AND PURPOSE: The myelin oligodendrocyte glycoprotein (MOG) antibody is detected at a high rate in childhood acquired demyelinating syndrome (ADS). This study aimed to determine the diagnostic value of the MOG antibody in ADS and the spectrum of MOG-antibody-positive demyelinating diseases in children. METHODS: This study included 128 patients diagnosed with ADS (n=94) or unexplained encephalitis (n=34). The MOG antibody in serum was tested using an in-house live-cell-based immunofluorescence assay. RESULTS: The MOG antibody was detected in 48 patients (46 ADS patients and 2 encephalitis patients, comprising 23 males and 25 females). Acute disseminated encephalomyelitis (ADEM) (35.4%) was the most-common diagnosis, followed by the unclassified form (17.4%), isolated optic neuritis (ON) (15.2%), neuromyelitis optica spectrum disorder (13.0%), multiple sclerosis (MS) (10.8%), other clinically isolated syndromes [monophasic event except ADEM, isolated ON, or transverse myelitis (TM)] (8.7%), and unexplained encephalitis (4.3%). At the initial presentation, 35 out of the 46 patients with ADS had brain lesions detected in magnetic resonance imaging, and 54% of these 35 patients had encephalopathy. Nine of the 11 patients without brain lesions exhibited only ON. Thirty-nine percent of the patients experienced a multiphasic event during the mean follow-up period of 34.9 months (range 1.4–169.0 months). Encephalopathy at the initial presentation was frequently confirmed in the monophasic group (p=0.011). CONCLUSIONS: MOG antibodies were identified in all pediatric ADS phenotypes except for monophasic TM. Therefore, the MOG antibody test is recommended for all pediatric patients with ADS, especially before a diagnosis of MS and for patients without a clear diagnosis. |
format | Online Article Text |
id | pubmed-7354962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Korean Neurological Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-73549622020-07-22 Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children Yoo, Il Han Kim, WooJoong Shim, Youngkyu Choi, Sun Ah Kim, Soo Yeon Kim, Hunmin Lim, Byung Chan Hwang, Hee Choi, Jieun Kim, Ki Joong Kim, Yeseul Hyun, Jae-Won Kim, Su-Hyun Choi, Kyungho Kim, Ho Jin Chae, Jong-Hee J Clin Neurol Original Article BACKGROUND AND PURPOSE: The myelin oligodendrocyte glycoprotein (MOG) antibody is detected at a high rate in childhood acquired demyelinating syndrome (ADS). This study aimed to determine the diagnostic value of the MOG antibody in ADS and the spectrum of MOG-antibody-positive demyelinating diseases in children. METHODS: This study included 128 patients diagnosed with ADS (n=94) or unexplained encephalitis (n=34). The MOG antibody in serum was tested using an in-house live-cell-based immunofluorescence assay. RESULTS: The MOG antibody was detected in 48 patients (46 ADS patients and 2 encephalitis patients, comprising 23 males and 25 females). Acute disseminated encephalomyelitis (ADEM) (35.4%) was the most-common diagnosis, followed by the unclassified form (17.4%), isolated optic neuritis (ON) (15.2%), neuromyelitis optica spectrum disorder (13.0%), multiple sclerosis (MS) (10.8%), other clinically isolated syndromes [monophasic event except ADEM, isolated ON, or transverse myelitis (TM)] (8.7%), and unexplained encephalitis (4.3%). At the initial presentation, 35 out of the 46 patients with ADS had brain lesions detected in magnetic resonance imaging, and 54% of these 35 patients had encephalopathy. Nine of the 11 patients without brain lesions exhibited only ON. Thirty-nine percent of the patients experienced a multiphasic event during the mean follow-up period of 34.9 months (range 1.4–169.0 months). Encephalopathy at the initial presentation was frequently confirmed in the monophasic group (p=0.011). CONCLUSIONS: MOG antibodies were identified in all pediatric ADS phenotypes except for monophasic TM. Therefore, the MOG antibody test is recommended for all pediatric patients with ADS, especially before a diagnosis of MS and for patients without a clear diagnosis. Korean Neurological Association 2020-07 2020-07-01 /pmc/articles/PMC7354962/ /pubmed/32657068 http://dx.doi.org/10.3988/jcn.2020.16.3.461 Text en Copyright © 2020 Korean Neurological Association http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Yoo, Il Han Kim, WooJoong Shim, Youngkyu Choi, Sun Ah Kim, Soo Yeon Kim, Hunmin Lim, Byung Chan Hwang, Hee Choi, Jieun Kim, Ki Joong Kim, Yeseul Hyun, Jae-Won Kim, Su-Hyun Choi, Kyungho Kim, Ho Jin Chae, Jong-Hee Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children |
title | Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children |
title_full | Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children |
title_fullStr | Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children |
title_full_unstemmed | Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children |
title_short | Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children |
title_sort | clinical spectrum of myelin oligodendrocyte glycoprotein-immunoglobulin g-associated disease in korean children |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354962/ https://www.ncbi.nlm.nih.gov/pubmed/32657068 http://dx.doi.org/10.3988/jcn.2020.16.3.461 |
work_keys_str_mv | AT yooilhan clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimwoojoong clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT shimyoungkyu clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT choisunah clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimsooyeon clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimhunmin clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT limbyungchan clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT hwanghee clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT choijieun clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimkijoong clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimyeseul clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT hyunjaewon clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimsuhyun clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT choikyungho clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT kimhojin clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren AT chaejonghee clinicalspectrumofmyelinoligodendrocyteglycoproteinimmunoglobulingassociateddiseaseinkoreanchildren |